Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial Article Proceedings Paper

sustainable development goals

authors

publication date

  • 2019

webpage

published in

keywords

  • Dyspareunia
  • Menopause
  • Ospemifene
  • Selective estrogen receptor modulator
  • Vaginal dryness

PubMed Central ID

  • PMC6553508

start page

  • 611

end page

  • 621

volume

  • 26

issue

  • 6